You need to enable JavaScript to run this app.
Recon: Moderna launches Phase 3 COVID-19 vaccine testing; AstraZeneca, Daiichi sign $6B deal for targeted cancer drug
Recon
Michael Mezher
ReconMichael Mezher
ReconMichael Mezher